Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1606 |
Fasudil
HA-1077,AT877,法舒地尔 |
ROCK; Serine/threonin kinase; Calcium Channel; PKA; PKC; Autophagy | Autophagy; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; Membrane transporter/Ion channel; Metabolism; Stem Cells; Tyrosine Kinase/Adaptors |
Fasudil (HA-1077) 是一种非特异性 RhoA/ROCK 抑制剂,也是 Ca2+通道拮抗剂和血管扩张剂。它对蛋白激酶有抑制作用,ROCK1 的 Ki 值为 0.33 μM,ROCK2 和 PKA、PKC、PKG 的 IC50值分别 0.158 μM 和 4.58 μM、12.30 μM、1.650 μM。 | |||
T3060 |
Fasudil hydrochloride
Fasudil (HA-1077) HCl,盐酸法舒地尔,HA-1077,Fasudil HCl,HA-1077 hydrochloride,AT-877 |
ROCK; Serine/threonin kinase; Calcium Channel; HIV Protease; PKA; PKC; Autophagy | Autophagy; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; Membrane transporter/Ion channel; Metabolism; Microbiology/Virology; Proteases/Proteasome; Stem Cells; Tyrosine Kinase/Adaptors |
Fasudil hydrochloride (HA-1077) 是一种非特异性RhoA/ROCK 抑制剂,也抑制蛋白激酶,对 ROCK1、PKA、PKC 和 MLCK 的 Ki 值分别为 0.33 μM、1.0 μM、9.3 μM 和 55 μM。 | |||
T23301 |
(S)-(+)-Niguldipine hydrochloride
|
Others | Others |
L-type Ca2+ channel blocker and α1A-adrenoceptor antagonist | |||
T77710 |
Calcium Channel antagonist 2
WAY-327363 |
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
Calcium Channel antagonist 2是一种 calcium channel 拮抗剂 (IC50=5-20 μM),可用于研究像疼痛和糖尿病等由于 Ca2+ 通道造成的疾病。 | |||
T16897 |
SM-6586
|
Na+/Ca2+ Exchanger; Sodium Channel | Membrane transporter/Ion channel |
SM-6586 是一种有效的钙离子通道拮抗剂,对 Na+/H+ 和 Na+/Ca2+ 交换通道有抑制作用,可用于研究脑血管疾病和高血压等疾病。 | |||
T8674 |
SR33805
|
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
SR33805 是钙通道拮抗剂,在去极化和极化条件下的 EC50值分别为 4.1 和 33 nM。它阻止 L 型 Ca2+通道,可用于研究急性或慢性心脏衰竭。 | |||
T13219 |
TTA-Q6
|
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
TTA-Q6 是一种选择性 T 型 Ca2+ 通道拮抗剂,具有潜在的抗肿瘤和免疫调节活性,可抑制肿瘤细胞摄取细胞外钙离子,诱导细胞内钙缺乏和内质网(ER)应激,用于治疗神经系统疾病。 | |||
T23391 | SR 33805 oxalate | Others | Others |
Ca2+ channel antagonist | |||
T28668 |
SB 201823-A
SB201823A,SB-201823-A |
||
SB 201823-A is a Ca2+ channel antagonist. | |||
T28489 | R-(-)-Niguldipine hydrochloride | ||
R-(-)-Niguldipine hydrochloride is a L-type Ca2+ channel blocker; potassium agonist that activates Ca2+-activated maxi K-channel; alpha1A-adrenoceptor antagonist; antihypertensive agent; Less active enantiomer. | |||
T23225 |
(R)-(-)-Niguldipine hydrochloride
|
Others | Others |
L-type Ca2+ channel blocker and α1A-adrenoceptor antagonist | |||
T30918 |
CI 951
CI-951,CI951 |
||
CI 951 is a novel dihydronaphthyl Ca2+ antagonist and channel blocker. | |||
T28572 |
Ro 23-7014
Ro-23-7014 |
||
Ro 23-7014, a new thiazepinone Ca2+ channel antagonist, has high affinity for peripheral (Type A) receptors. | |||
T13220 |
TTA-Q6(isomer)
|
Others | Others |
TTA-Q6(isomer) is an isomer of TTA-Q6. TTA-Q6 is a selective antagonist of the T-type Ca2+ channel. | |||
T26970 |
CD-349
CD 349,CD349 |
||
CD-349 is a calcium channel antagonist. CD-349 inhibits the noradrenaline (NA)-induced contraction of aortas in Ca2(+)-free medium. | |||
T71406 | SA 2572 | ||
SA 2572 is a newly synthesized Ca2+ antagonist having a inhibitory effect on the fast Na+ inward channel. | |||
T28172 |
Niguldipine hydrochloride
BY-935,Niguldipine HCl,B-85935,B-8509-035,B-859-35 |
||
Niguldipine is a calcium channel antagonist. Niguldipine shows high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptors. | |||
T70036 |
AJG-049 HCl
|
||
AJG-049 HCl is a calcium channel antagonist that inhibits L-type Ca2+ channels via diltiazem-binding site(s). | |||
T12880 |
Semotiadil recemate fumarate
|
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
Semotiadil recemate fumarate is the recemate of Semotiadil fumarate. Semotiadil fumarate is a novel antagonist of vasoselective Ca2+ channel. | |||
T70682 |
AJ-3941
|
||
AJ-3941 is a cerebrovascular-selective Ca2+ channel antagonist with anti-lipid peroxidative action. AJ-3941 may be useful in the treatment of cerebrovascular disorders. | |||
T70037 |
AJG-049 free base
|
||
AJG-049 free base is a calcium channel antagonist that inhibits L-type Ca2+ channels via diltiazem-binding site(s). | |||
T36808 | UK 59811 hydrochloride | ||
Blocks CaVAb, a site-directed mutant of bacterial NaVAb with full voltage-dependent Ca2+ channel function (IC50 = 194 nM). Tang et al (2016) Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs. Nature 537 117 PMID:27556947 | |||
TP1909 |
CALP2
|
||
Cell-permeable calmodulin (CaM) antagonist that binds to the EF-hand/Ca2+-binding site. CALP2 has been demonstrated to inhibit CaM-dependant phosphodiesterase activity and increase intracellular Ca2+ concentrations by modulating Ca2+-channel activity. CAL | |||
T33673 |
Niludipine
Niludipina,BAY-a 7168,Bay a 7168,Niludipinum |
||
Nirudipine is a double (2-propoxyethyl) analogist of nifedipine and a calcium channel blocker, which is also a safe anti-angina Ca2+ antagonist with a broad range of efficacy for all types of angina. At the same time, Niludipine is a highly effective drug | |||
T62243 |
Bepridil hydrochloride hydrate
|
||
Bepridil hydrochloride hydrate ((±)-Bepridil hydrochloride hydrate) 是一种长效的、非选择性的钙离子通道 (Ca+channel) 拮抗剂。Bepridil hydrochloride hydrate 是一种钠离子、钾离子通道 (Na+,K+channel) 抑制剂,也是心脏 Na+/Ca2+交换 (NCX1) 抑制剂。Bepridil hydrochloride hydrate 具有抗心绞痛和抗 I 型心律失常作用,能够用于研究心血管疾病。 |